Articles for "Oil" (5 posts)

Mansfield-Martin Exploration Mining, Inc. (MCPI: OTC Pink Current) | Tier Change

Sat, Sep 23, 2017 12:00 – Mansfield-Martin Exploration Mining, Inc. (MCPI: OTC Pink Current) – Tier Change – The symbol, MCPI, no longer is classified as OTC Pink Limited. As of Sat, Sep 23, 2017, MCPI resides in the OTC Pink Current tier. You may fin…

read more

VNR Fin Corp. (VNRR: OTC Pink No Information) | Tier Change

Sat, Sep 23, 2017 12:00 – VNR Fin Corp. (VNRR: OTC Pink No Information) – Tier Change – The symbol, VNRR, no longer is classified as OTC Pink Current. As of Sat, Sep 23, 2017, VNRR resides in the OTC Pink No Information tier. You may find a complete l…

read more

VNR Fin Corp. (VNRRW: OTC Pink No Information) | Tier Change

Sat, Sep 23, 2017 12:00 – VNR Fin Corp. (VNRRW: OTC Pink No Information) – Tier Change – The symbol, VNRRW, no longer is classified as OTC Pink Current. As of Sat, Sep 23, 2017, VNRRW resides in the OTC Pink No Information tier. You may find a complet…

read more

VNR Fin Corp. (VNRWW: OTC Pink No Information) | Tier Change

Sat, Sep 23, 2017 12:00 – VNR Fin Corp. (VNRWW: OTC Pink No Information) – Tier Change – The symbol, VNRWW, no longer is classified as OTC Pink Current. As of Sat, Sep 23, 2017, VNRWW resides in the OTC Pink No Information tier. You may find a complet…

read more

Medical Marijuana, Inc. Portfolio Company KannaLife Sciences Announces Nick Lowery as New Spokesperson

On September 22nd, 2017, posted in: News Feed by

SAN DIEGO, Sept. 22, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) portfolio company, Kannalife Sciences, Inc., a pharmaceutical and phyto-medical company, announced today that former three time NFL Pro-Bowl and Kansas City Chiefs placekicker, Nick Lowery, has joined Kannalife corporate advisory board to lead the Company’s initiative on speaking about chronic traumatic encephalopathy (CTE) and Kannalife’s efforts to bring forth a clinically approved treatment for CTE. Kannalife Sciences holds the exclusive license from the federal government to commercialize a cannabinoid patent currently held by the U.S. Government and National Institutes of Health (NIH).

read more